2022
DOI: 10.1016/j.compbiomed.2022.105648
|View full text |Cite
|
Sign up to set email alerts
|

Optimized convolution neural network based multiple eye disease detection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(8 citation statements)
references
References 20 publications
0
1
0
Order By: Relevance
“…Deep learning has been demonstrated to achieve remarkable results in eye detection tasks, including glaucoma and DR, in recent years. [10], [37]- [39]. Therefore, our proposed model leverages DCGAN to synthesize high-quality images and utilizes the CNN ensemble method for classification.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Deep learning has been demonstrated to achieve remarkable results in eye detection tasks, including glaucoma and DR, in recent years. [10], [37]- [39]. Therefore, our proposed model leverages DCGAN to synthesize high-quality images and utilizes the CNN ensemble method for classification.…”
Section: Methodsmentioning
confidence: 99%
“…The DVE algorithm achieves superior accuracy rates on both the DDR and EyePACS datasets, validating its effectiveness in fine grading of DR images. As a future work, the performance of the proposed model can be compared with the performance of a capsule network-based approach because capsule networks can preserve spatial relationships of learned features and have been used recently for recognitions and classifications[37]-[39].…”
mentioning
confidence: 99%
“…Tan et al [6] applied a deep CNN for predicting AMD with 10-fold cross-validation principle. Gulshan et al [7] used DL for automated prediction of DR and DME in retinal fundus images on EyePACS-1 dataset as well as Messidor-2 dataset, correspondingly.…”
Section: Literature Reviewmentioning
confidence: 99%
“…The first ophthalmic AI device, IDx-DR, was approved for listing with landmark significance on 11 April 2018, opening a new chapter on the combination of AI with ophthalmology. Since then, the application of AI in the ophthalmology has entered a new stage of development, leading to a series of satisfactory research results in the diagnosis, classification, recognition, and screening of ophthalmic diseases, such as diabetic retinopathy (Deepa et al, 2022;Hardas et al, 2022;, age-related macular degeneration (Glaret Subin and Muthukannan, 2022;Sotoudeh-Paima et al, 2022;, retinopathy of prematurity (Coyner et al, 2022;Wu et al, 2022), glaucoma (Dong et al, 2022;Xiong et al, 2022), and retinal vein occlusion (Miao et al, 2022;Ren et al, 2022;.…”
Section: Introductionmentioning
confidence: 99%